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Abstract 
Introduction. Long interspersed nuclear elements-1 (L1), as the only one self-active retrotransposon of the 
mobile element, was found to be generally activated in tumor cells. The 5‘UTR of L1 (L1-5’UTR) contains 
both sense and antisense bidirectional promoters, transcription products of which can generate double-strand 
RNA (dsRNA). In addition, L1-ORF1p, a dsRNA binding protein encoded by L1, is considered to engage in 
some RNA-protein (RNP) formation. Ago2, one of the RISC components, can bind to dsRNA to form RISC 
complex, but its role in L1 regulation still remains unclear. Due that the 5‘UTR of L1 (L1-5’UTR) contains both 
sense and antisense bidirectional promoters, so the activities in both string were identified. A dsRNA-mediated 
regulation of L1-5’UTR, with the feedback regulation of L1-ORF1p as well as other key molecules engaged 
(Ago1–4) in this process, was also investigated. 
Material and methods. Genomic DNA was extracted from HEK293 cells and subjected to L1-5’UTR prepa-
ration by PCR. Report gene system pIRESneo with SV40 promoter was employed. The promoter activities of 
different regions in L1-5’UTR were identified by constructing these regions into pIRESneo, which SV40 region 
was removed prior, to generate different recombinant plasmids. The promoter activities in recombinant plasmids 
were detected by the luciferase expression assay. Western blot and co-immunoprecipitation were employed to 
identify proteins expression and protein-protein interaction respectively.
Results. Ago2 is a member of Agos family, which usually forms a RISC complex with si/miRNA and is involved 
in post- transcriptional regulation of many genes.  Here L1-ORF1p and Ago2 conducts a regulation as a negative 
feedback for L1-5'UTR sense promoter. L1-ORF1p could form the immune complexes with Ago1, Ago2 and 
Ago4, respectively. 
Conclusions. L1-5’UTR harbors both sense and antisense promoter activity and a dsRNA-mediated regulation 
is responsible for L1-5’UTR regulation. Agos proteins and L1-ORF1p were engaged in this process. (Folia 
Histochemica et Cytobiologica 2019, Vol. 57, No. 2, 56–63)
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Introduction
LINE-1 (Long Interspersed Nucleotide Element, 
L1), an autonomous retrotransposon and a parasitic 
element, makes up roughly 20% of human genomic 
DNA. It spreads throughout human genome by 
a manner of “copy and paste” that propagates its 
DNA or other DNAs within the genome through 
RNA intermediate and the mechanism is termed as 
target-primed reverse transcription (TPRT) [1, 2]. 
L1, in human genome, is thought to be activated in 
germ cell, embryonic cells with early stage of devel-
opment [3]. Promoter hypermethylation is a common 
phenomenon  for gene deactivation; however, its 
deactivation is related to promoter hypermethylation 
in differentiated cells by epigenetic regulation. In 
addition, L1 as a cis-element can also suppress adja-
cent gene expression due to unknown mechanism [4]. 
Moreover, it has been reported that the promoter of 
L1 provides an alternative promoter site for the ex-
pression of other nearby genes. The translocation of 
L1 containing the 5’UTR promoter sequence to the 
intron region of the Met gene was observed in colorec-
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tal and liver cancer. This phenomenon has been 
shown to be associated with an abnormal increase 
in Met expression and is important for malignant 
proliferation of cancer cells [5]. Under stress con-
dition, e.g.: heat shock, virus infection, treating by 
cycloheximide, genotoxic agents and DNA base ana-
logs, L1 can also be activated. The hypermethylation 
of L1 promoter occurs early in non-small-cell lung 
cancer (NSCLC), which is independently associated 
with poor prognosis in stage I NSCLC patients [6]. 
Physiologically, L1 is considered to be involved in 
X chromosome inactivation by a Xist mechanism [7]. 
Activated L1 not only reshapes the genome by aris-
ing gene mutations including insertion, deletion and 
rearrangement, but also contributes to modulation of 
gene expression by epigenetic mechanism. Given that 
L1 can lead to deleterious effects, it is important for 
cell to constrain its activation; however, this gene was 
identified to be activated ubiquitously in malignant 
tumor cells [8–10]. It is reported that L1 induces 
hTERT and ensures telomere maintenance in tumor 
cell lines [11]. Decreased expression of E-Cadherin 
and N-Cadherin proteins were observed post L1- 
-ORF2p (L1 encoded ORF2 protein) transfection 
along with up-regulation of vimentin [12]. Thus, L1 
with its feature of widespread distribution in human 
genome and ubiquitous activation in tumor cells can 
act as a promising model for us to understand the 
mechanism of tumorigenesis. 
Full-length L1, 6–7kb, is consisted of a 5’ untrans-
lated region (5’-UTR), two open reading frames 
(ORF1 and ORF2) and a 3’-UTR. L1-ORF1p (L1 
encoded protein ORF1 protein), a RNA-binding 
protein facilitating retrotransposition together with 
L1-ORF2 p [13], was identified to co-localize with 
RNA-induced silencing complex (RISC) recently [14, 
15]. 5’-UTR of L1 containing a sense promoter (SP) 
and an antisense promoter (ASP) will generate a dou-
ble-strand RNA (dsRNA) after transcription [16, 17], 
which implicates an RNA interference mechanism for 
its regulation. With the constructs of full-length and 3’ 
truncated mutants of L1-5UTR, the promoter activity 
of L1 was investigated. At the same time, L1-ORF1p 
as a RNA binding protein was also identified for its 
function in this process.
The regulation of siRNA trafficking in human 
cells is executed by RNA-induced silencing com-
plex (RISC). Small interfering RNA molecules are 
bound to RISC complex followed by inference with 
corresponding mRNA in cytoplasm. It was previously 
observed, that L1-5’UTR is negatively regulated by 
RISC via interaction with Ago2 (Argonaut family 
protein) [18]. However, the exact role of Ago2 (and 
other proteins of Ago family; Ago1, 3, 4) in regula-
tion negative feedback mechanism of L1 still remains 
unknown. Therefore, next aim of our study was to 
check whether the Ago2 protein interacts with L1 
particles.
Materials and methods
Cell culture. HEK293 cells were cultured with DMEM me-
dium (Gibco-BRL, Gaithersburg, MD, USA) supplemented 
with 10% fetal calf serum (Hyclone, Logan, UT, USA). 
Cells were incubated at 37° with an atmosphere containing 
5% CO2 and saturated humidity. The medium was changed 
every 2–3 days.
Recombinant plasmids construction. PCR regents were 
purchased from Takara Company (Beijing, China) and 
the approach was followed according to manufacturer’s 
protocol. In brief, the components of PCR reaction were as 
follows: 2 µl DNA template, 1 µl upstream primer (10 mmol/ 
/ml) and downstream primer (10 mmol/ml) respectively, 
10 µl of 2 × PCR master mixture (including: Taq, dNTP and 
buffer), H2O to a 20 µl final reaction volume. PCR running 
parameters were as follows: 95°C for 5 min followed by 
35 cycles of 94°C for 5 s, annealing at 58°C for 25 s, extension 
at 70°C for 25 s, and a final extension at 70°C for 10 min. 
L1-ORF1p recombinant plasmid: The full-length sequence 
of L1-ORF1 was amplified by PCR with a template of hu-
man genome DNA and cloned into pIRESneo to generate 
recombinant plasmid pIRES-ORF1-Flag. 
L1-5’UTR recombinant plasmids: pCBG99-5UTR-FL: Full-
length L1-5’UTR was amplified by PCR with a template of 
human genome DNA and primers (5’-CCGCTCGAG(Xho-
lI)GAGAGGAGCCAAGATGGC-3’and 5’-CCCAAGCT-
T(HindIII)CTTTGTGGTTTTATCTACTTT-3’). PCR 
products were cloned into pCBG99-control vector digested 
with XholI/HindIII (removing SV40 promoter) prior to 
generate pCBG99-5UTR-FL. 
pCBG99-5UTR-680 and pCBG99-5UTR-400: 
For constructing 3’- truncated mutants of L1-5’UTR, 
5’UTR-680 (removing ASP sequence) and 5’UTR-400 (re-
moving ASP and partial SP sequences) of L1-5’UTR were 
amplified by PCR with a template of pCBG99-5UTR-FL 
and specific primers
(5’UTR-680:  5 ’ -CCGCTCGAG(XholI)GAGAG-
GAGCCAAGATGGC-3’ and 5’-CCCAAGCTT(Hin-
dIII) GCAGTCTGCCCGTTCTCAGA-3; 5’UTR-400: 
5’-CCGCTCGAG(XholI)GAGAGGAGCCAAGAT-
GGC-3’, and 5’-CCCAAGCTT(HindIII) TGCAGTTT-
GATCTCAGACTG-3’). 
PCR products were cloned into pCBG99-control vector 
digested by XholI/HindIII prior to generate pCBG99- 
-5UTR-680 and pCBG99-5UTR-400, respectively.
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pCBG99-actin 680: As a negative control, the sequence of 
beta-actin with 680bp was prepared by PCR with a template 
of genomic DNA and primers (5’-CCGCTCGAG (XholI)
CTGTGCCCATCTACGAGG-3’and5’-CCCAAGCT-
T(HindIII)AAAGGGTGTAACGCAACTAA-3’). PCR 
product was cloned into pCBG99-control digested by XholI/ 
/HindIII prior to generate pCBG99-actin 680.
pCBG99-5UTR-aFL and pCBG99-5UTR-a680: For 
investigating ASP activity, antisense sequence of full-length 
of L1-5’UTR were prepared by PCR with the primers as 
follows: 
5’-CCCAAGCTT (HindIII) GAGAGGAGCCAAGAT-
GGC-3’ and 5’-CCGCTCGAG(XholI) CTTTGTGGT-
TTTATCTACTTT-3’. 
Antisense sequence of 3’ truncated mutant of 5 ’UTR- 
680 was prepared by PCR with the primers as follows: 
5’-CCCAAGCTT(HindIII) GAGAGGAGCCAA-
GATGGC-3’ and 5’-CCGCTCGAG(XholI)GCAG 
TCTGCCCGTTCTCAGA-3. 
PCR products were cloned into pCBG99-control digest-
ed by XholI/HindIII prior to generate pCBG99-5UTR-aFL 
and pCBG99-5UTR-a680, respectively. 
Ago2 recombinant plasmids: pSilencer-Ago2-siRNA1, 
pSilencer-Ago2-siRNA2, pSilencer-Ago2-Con1, 
pSilencer-Ago2-Con2: siRNA targeting sequences 
for Ago2 were designed by RNAi designer (Ambion, 
USA), two candidates were selected with the sequenc-
es as follows: 
5’-ACCGAGTTCGACTTCTACCTGTGTA-3’and 
5’-CAAGACACTCTGCGCACCATGTACT-3’
The hairpin structure was designed with the sequences 
as follows:
siRNA1 gene: sense sequence, 5’-GATCCACCGAGT-
TCGACTTCTACCTGTGTATTCAAGAG ATACA-
CAGGTAGAAGTCGAACTCGGTTTTTTTGGAAA-3’; 
anti-sense sequence: 
5’-AGCTTTTCCAAAAAAACCGAGTTCGACTTC-
TACCTGTGTATCTCTTGAATACACAGGTAGAA-
GTCGA ACTCGGTG-3’;
siRNA2 gene: sense sequence,5’-GATCCCAAGA-
CACTCTGCGCACCATGTACTTTCAAGAG AAGTA-
CATGGTGCGCAGAGTGTCTTGTTTTTTGGAAA-3’;
anti-sense sequence: 
5’-AGCTTTTCCAAAAAACAAGACACTCTGCGCAC-
CATGTACTTCTCTTGAAAGTACATGGTGCGCA-
GAGTGTCTTGG-3’. 
Double strand sequence was prepared by annealing and 
ligated into pSilencer2.1-U6/neo (Abcam, Cambridge, 
MA, USA) to generate recombinant plasmid pSilenc-
er2.1-Ago2-siRNA1 and pSilencer2.1-Ago2-siRNA2, 
respectively. With same procedure, the control sequences 
for siRNA1 (con-siRNA1: 5’-ACCTGCTAGTCCTATC-
CGTTAGGTA-3’) and siRNA2 (con-siRNA2: 5’-CAA-
CACTCTGCGCACTACTGGAACT-3’) were designed, 
synthesized and cloned into pSilencer2.1-U6/neo to gen-
erate pSilencer-Ago2-Con1 and pSilencer-Ago2-Con2, 
respectively.
Western blot analysis. The recombinant plasmids (pSi-
lencer-Ago2-siRNA1, pSilencer-Ago2-siRNA2, pSilenc-
er-Ago2-Con1, pSilencer-Ago2-Con2) were transfected into 
HEK293 cells using LipofectamineTM2000 reagent (Invit-
rogen, Carlsbad, CA, USA) for 48 h. Harvested cells were 
lysed with the lysis buffer (PBS solution including 2 µg/ml 
aprotinin, 100 µg/ml phenylmethyl-sulphonyl ﬂuoride, 
2 µg/ml leupeptin and 1% Nonidet P-40 (Beyotime, 
Shanghai, China) followed by centrifugation to remove 
unsolved debris. After fractionating by 12.5% SDS-PAGE, 
the proteins were transferred into nitrocellulose mem-
brane (Bio-Rad Laboratories, Hercules, CA, USA). The 
membranes were incubated with 5% non-fat milk for 1 h 
in room temperature and then with the primary antibody 
(anti-Ago2, anti-FLAG, anti-beta-actin, Abcam) for addi-
tional 1 h followed by washing with TBST (Tris Buffered 
Saline Tween) for three times. The membranes were incu-
bated with horseradish peroxidase-labeled second antibody 
(Sigma, St Louis, MO, USA) for 1 h and washed with TBST 
for three times. The signals were visualized by incubating 
with enhanced chemiluminescence reagent (Amersham, 
Little Chalfont, UK) for 5 min. Triplicate experiments were 
conducted independently.
Luciferase expression assay. HEK293 cells were cultured 
with DMEM containing 0.5% calf serum for 24 hours, 
followed by transfection using 1 µg pCMV-b-gal (internal 
reference) combing with 1 µg different constructs. After 
culturing for 1 h the transfected cells were lysed and sub-
jected to luciferase and b-Galactosidase assay respectively 
(Promega, Shanghai, China). The values of luciferase in 
different groups were normalized by b-Galactosidase to 
eliminate differences elicited by transfection efficiency. 
Triplicate experiments were conducted independently.
Co-immunoprecipitation. The cells were harvested 
and incubated with lysis buffer (20 mM Tris HCl pH 8, 
137 mM NaCl, 10% glycerol, 1% Nonidet P-40, 2 mM EDTA) 
including a cocktail of protease inhibitors (Roche, Basel, 
Switzerland) on ice for 5 min. The supernatant solution 
was prepared by centrifuging with 15000 rpm for 10 min at 
4°C. 200 µl cell lysate and 20 µl 50% bead slurry (protein-A 
sepharose) were mixed and incubated with gently rocking 
for 3–4 h at 4°C. Supernatant solution was collected and 
incubated with 5 µl anti-FLAG by gently rocking for 4 h 
at 4°C. After spinning down and washing, the pellet was 
re-suspended with 20 µl 2 × SDS buffer, heated at 95–100°C 
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for 2–5 min and then subjected to SDS-PAGE analysis. The 
proteins were identified by immune blot using anti-Ago1, 
anti-Ago2, anti-Ago3, anti-Ago4 antibodies, respectively 
(Abcam, Shanghai, China).
Statistical analysis. Differences between experiment groups 
and control were tested using SPSS software v. 11.0 (IBM, 
New York, NY, USA), in which p < 0.05 were considered 
as significant differences.
Results
Construction of the L1-5’UTR mutants 
To elucidate the promoter activity of L1-5’UTR, the 
full-length and 3’ mutants of L1-5’UTR were con-
structed with SV40-removed luciferase report system 
and confirmed by sequencing. The schematic map and 
recombinant plasmids for confirming constructs were 
shown in Figure 1.
The activity of SP and ASP in L1- 5’UTR  
were identified 
With report system construct of luciferase, the pro-
moter activities of sense and antisense in L1-5’UTR 
were identified quantitatively. As indicated in Figure 2, 
both activity of SP and ASP in L1-5’UTR were eval-
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Figure 1. The constructs of full-length and truncated L1-5’UTR. A. A schematic map of construction of L1-5’UTR and 
mutants. 1: pCBG99-5UTR-FL (903bp); 2: pCBG99-5UTR-680 (680bp); 3: pCBG99-5UTR-400 (400bp); 4: pCBG99-actin 
680 (680bp); 5: pCBG99-5UTR-aFL (903bp); 6: pCBG99-5UTR-a680 (680bp); B. The different constructs were confirmed 
by electrophoresis. DNA sizes of L1-5’UTR in different constructs were confirmed by digesting with restrictive enzymes as 
described in materials and methods. M: DNA molecular marker (2000bp, 1000bp, 750bp, 500bp, 250bp, 100bp); 1: pCBG99- 
-5UTR-FL (903bp); 2: pCBG99-5UTR-680 (680bp); 3: pCBG99-5UTR-400 (400bp); 4: pCBG99-actin 680 (680bp); 5: pCBG99- 
-5UTR-aFL (903bp); 6: pCBG99-5UTR-a680 (680bp). Arrows in Fig. 1B mean the different amplicons mentioned above.
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Figure 2. The identification of promoter activities of L1-
-5’UTR in sense and antisense sequences. The sense and 
antisense sequences of L1-5’UTR were constructed in 
immediately upstream of luciferase gene in SV40-removed 
pCBG99. The relative values of luciferase expressions in 
different groups were detected as described in Materials and 
methods. Con: pCBG99-Control (100%); s-FL: pCBG99- 
-5UTR-FL (40%); as-FL: pCBG99-5UTR-aFL (16%). The 
percentages in parentheses are relative values of luciferase 
expression compared with control. The value in each group 
is the mean of triplicates and SEM were labeled by whiskers 
over the bars
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uated by comparing with SV40 and indicated that SP 
was much stronger than ASP.
ASP can suppress SP activity 
Owing to transcripts from SP and ASP in L1-5’UTR 
will generate a dsRNA, the effect of dsRNA on SP 
activity was investigated by constructing different 
ASP mutants. pCBG99-5UTR-680, a construct 
with 223bp removing in 3 terminus of 5’UTR, and 
pCBG99-5UTR-400, a construct with 503bp removing 
in 3 terminus of 5’UTR displays the strongest and 
weakest SP activity respectively by comparing with 
pCBG99-5UTR-FL, a construct with full-length of 
L1-5’UTR. Meanwhile, the remaining ASP activity 
in these truncated mutants was also determined by 
constructing pCBG99-5UTR-a680 and pCBG99- 
-5UTR-a400 (data not shown) (Fig. 3). Apparently, 
ASP activity negatively regulates SP activity and 
a dsRNA-mediated regulation was responsible for 
this mechanism.
Argonaut 2 is involved in siRNA-mediated  
regulation for L1-5’UTR 
To elucidate a dsRNA-mediated regulation further, 
Argonaut 2 (Ago2), a key component of RISC 
(RNA-induced Silencing Complex) playing an im-
portant role in siRNA processing was investigated. 
Co-transfection of constructs of Ago2-siRNA with 
either pCBG99-5UTR-680 or pCBG99-5UTR-400 
or pCBG99-5UTR-FL was conducted. As indicat-
ed in Figure 4, luciferase expression in construct 
of pCBG99-5UTR-FL was increased significantly, 
whereas moderate and null increases were shown 
in constructs of pCBG99-5UTR-680 and pCBG99-
Figure 3. Antisense sequence of L1-5’UTR negatively regu-
lates its promoter activity. Different constructs of L1-5’UTR 
were transfected into HEK293 cells. The expression of lucif-
erase in different groups was detected and the relative values 
were calculated by normalizing with control as describing 
in Materials and methods. Con: pCBG99-Control (100%); 
s-FL: pCBG99-5’UTR-FL (40%); s-680: pCBG99-5’UTR-680 
(120%); s-400: pCBG99-5’UTR-400 (18%); as-FL: pCBG99-
-5’UTR-aFL (16%); as-680: pCBG99-5’UTR-a680 (5%). The 
percentages in parentheses are relative values of luciferase 
expression compared with control. *p < 0.05; **p < 0.01
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Figure 4. Ago2 is involved in the regulation of L1-5’UTR activity. HEK293 cells were transfected by either pCBG99-5UTR-FL 
or pCBG99-5UTR-680 combined with Ago2-siRNA constructs. The expressions of luciferase in different groups were detected 
by measuring the OD value at 415 nm absorbance the relative values were calculated by normalizing with respective control 
(transfected by either pCBG99-5UTR-FL or pCBG99-5UTR-680 only). Ago2-siRNA1: pSilencer-Ago2-siRNA1; Ago2-con1: 
pSilencer-Ago2-Con1; Ago2-siRNA2: pSilencer-Ago2-siRNA2; Ago2-con2: pSilencer-Ago2-Con2 s-FL: pCBG99-5’UTR-
-FL; s-680: pCBG99-5’UTR-680. A. The expressions of Ago2 in transfected HEK293 cells with different siRNA constructs 
where assessed by Western blot. B. The relative values of luciferase expressions. S-FL: Ago2-con1 (100%); Ago2-siRNA1 
(280%); Ago2-con2 (100%); Ago2-siRNA2 (170%); S-680: Ago2-con1 (100%); Ago2-siRNA1 (110%); Ago2-con2 (100%); 
Ago2-siRNA2 (105%). The percentages in parentheses are relative values of luciferase expression compared with control 
The value in each group is the mean of triplicates and SEM were labeled by whiskers over the bars *p < 0.05; **p < 0.01
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-5UTR-400, respectively. Suggesting that Ago2 can 
suppress L1-5’UTR promoter activity and the mech-
anism by which a siRNA-mediated regulation may 
account for this fact.
L1-ORF1p is involved in siRNA-mediated  
regulation for L1-5’UTR
Given the RNA binding activity of L1-ORF1p, the ef-
fect of L1-ORF1p on siRNA-mediated regulation for 
L1-5’UTR was investigated. With different constructs 
of L1-5’UTR, the promoter activity was investigated in 
L1-ORF1p over-expressed HEK293 cells. As indicat-
ed in Figure 5, over-expression of L1-ORF1p resulted 
in decrease of luciferase expression significantly in 
full-length 5’UTR construct, whereas less effect on 
other truncated mutants. It indicates that L1-ORF1p 
is involved in siRNA-mediated L1-5’UTR regulation.
L1-ORF1p can form immune complex  
with the members of Argonaut family
Owing that both L1-ORF1p and Ago2 are RNA-bind-
ing proteins, the interaction between them was inves-
tigated with which may account for the mechanism of 
L1-ORF1p. As indicated in Figure 6A, a RNA-inde-
pendent interaction between Ago2 and L1-ORF1p was 
identified by co-immunoprecipitation. Furthermore, 
the other members of Argonaut family in human 
were also investigated and indicated that Ago1, Ago2, 
Ago4 but not Ago3 can form immune complex with 
L1ORF1p, respectively (Fig. 6B). Thus, the interaction 
between Ago2 (or other members of Argonaut family) 
and L1-ORF1p may account for the mechanism of 
L1-ORF1p for its feedback regulation to L1-5’UTR.
Figure 6. L1ORF1p formed a complex with the members of Argonaut family, Ago1, Ago2 and Ago4. Transfected HEK293 
cells were lysed and subjected to immunoprecipitation with anti-L1ORF1p. The complexes were fractionated by SDS-PAGE 
and immune-blotted with anti-Ago1, anti-Ago2, anti-Ago3 and anti-Ago4, respectively. 1: pIRES-L1ORF1-Flag; 2: pIRES 
(control). A. RNA-independent interaction of L1-ORF1p and Ago2. B. The interactions of L1-ORF1p with other members 
of Argonaut family, Ago1 and Ago4.
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Figure 5. L1-ORF1p modulated L1-5’UTR activity. pIRES-
ORF1-Flag was co-transfected with one of constructs of 
L1-5’UTR in HEK293 cells and the expressions of luciferase 
in different groups were detected by measuring the OD 
value at 415 nm absorbance. After normalizing with control 
(co-transfection of pIRES-Flag with pCBG99-Control), the 
relative values of expression in different groups were plotted. 
Con: pCBG99-Control (pIRS-FLAG: 100%, pIRS-ORF1-
FLAG: 97%); s-FL: pCBG99-5UTR-FL (pIRS-FLAG: 
40%, pIRS-ORF1-FLAG: 19%); s-680: pCBG99-5UTR-680 
(pIRS-FLAG: 112%, pIRS-ORF1-FLAG: 110%); s-400: 
pCBG99-5UTR-400 (pIRS-FLAG: 19%, pIRS-ORF1- 
-FLAG: 18%). The percentages in parentheses are relative 
values of luciferase expression compared with control. The 
value in each group is the mean of triplicates and SEM were 
labeled by whiskers over the bars **p < 0.01
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Discussion
SP and ASP in L1-5’UTR were identified for their 
activities by different constructs with luciferase report 
system. To elucidate a dsRNA (siRNA precursor) 
mediated regulation for L1-5’UTR, we construct-
ed differently truncated mutants of 3’ terminus of 
L1-5’UTR (removing ASP sequence) and found that the 
activity of SP has a negative relationship with ASP. It is 
implicated that a siRNA mediated regulation was em-
ployed for L1-5’UTR. Furthermore, Ago2, a critical 
component in RISC (RNA- Induced Silencing Com-
plex) [18] was investigated and, resultantly, a negative 
regulation for L1-5’UTR was identified. Our result is 
consistent with previous report, in which L1-5’UTR 
transcripts was identified as the first endo-siRNA in 
germ cells and L1 retrotransposition was suppressed 
by endogenously encoded small interfering RNAs [19] 
and Ago2 [14, 20]. Thus, Ago2 plays a crucial role in 
siRNA-mediated regulation for L1-5’UTR. Consist-
ently, the depletion of endo-siRNA was reported in 
human breast cancer cells. In addition, L1-ORF1p, 
a RNA binding protein and co-localizing with RISC 
[14], is also involved in a negative feedback regulation 
of L1-5’UTR by siRNA-mediated mechanism. Given 
that both Ago2 and L1-ORF1p are RNA binding 
proteins, an interaction was hypothesized and as 
a result that L1ORF1p can form immune complex with 
Ago2 with RNA independent manner even that the 
domains responsible for direct interaction need to be 
identified further. In addition, more members. but not 
Ago3, of Argonaut family (Ago1, Ago2, Ago4) were 
identified to interact with L1-ORF1p, suggesting that 
L1-ORF1p is involved in both siRNA and miRNA 
regulation based on the fact that Ago2 usually forms 
a complex with siRNA and Ago1/Ago4 usually forms 
a complex with miRNA [21]. Usually, Argonaut pro-
teins and miRNAs/siRNAs are localized in processing 
bodies and, under stress conditions, re-localized to 
stress granules where it results in mRNA cleavage 
with miRNA/siRNA-dependent manner [21]. So, the 
interaction of L1-ORF1p with Argonauts may also 
account for that L1-ORF1p is involved in the process 
of miRNA/siRNA maturing and processing. 
Taken together, both SP and ASP are identified 
in L1-5’UTR and a siRNA mediated regulation is 
identified for L1-5’UTR. L1-ORF1p, a RNA bind-
ing protein, is involved in siRNA mediated feedback 
regulation for L1-5’UTR by forming a complex with 
Ago1, Ago2 and Ago4, respectively. 
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